The ECM’s degradation by MMP13 can release sequestered growth factors, such as fibroblast growth factors (FGFs) and transforming growth factors (TGFs), which aid tumour cell proliferation and are also key to upregulating matrix stiffness [77,78]. The gene discussed is MMP13; the disease is neoplasm.